Live Update 
From the Liveblog of
Wednesday, April 29, 2020
From the Liveblog of
Wednesday, April 29, 2020
German company begins testing possible vaccine on human volunteers
Add ToI as a Preferred Source on GoogleGerman pharmaceutical company BioNTech says it has begun testing a potential vaccine for the new coronavirus on volunteers.
BioNTech, which is working with US-based Pfizer, says that 12 participants of a clinical trial in Germany have received doses of the vaccine candidate BNT162 since April 23.
Numerous pharmaceutical companies are racing to deliver a vaccine for the virus that has caused a pandemic and led to more than 215,000 deaths worldwide and sickened at least three million people.
BioNTech says in a statement that in a next step, it will begin increasing the dose of BNT162 in a trial involving about 200 participants aged 18 to 55.
The company says it expects to receive regulatory approval to begin trials in the United States soon.
— AP
If you’d like to comment, join
The Times of Israel Community.
The Times of Israel Community.
JOIN THE TOI COMMUNITY
Already a member? Log in here